How mission plus performance can lead to sustainable success.

Medtronic has received CE marks under the European Union’s Medical Device Regulation (EU MDR) for the BrainSense adaptive deep brain stimulation (aDBS) system and electrode identifier (EI) for ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

The latter is necessary in order to have invasive IPG exchange in time without therapy loss. Currently, the Medtronic Access controller is the most commonly used DBS patient controller.

Innovation has “created a tailwind for the company that that we haven’t had in a long time,” Medtronic CEO Geoff Martha said at the 2025 J.P. Morgan Healthcare ... “It’s the world’s first complete ...

The CE Mark approval underscores the potential of adaptive DBS to improve symptom management.” Medtronic is the originator of continuous deep brain stimulation (cDBS), which has been available for ...

Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

The company announced Monday that it received Europe’s CE mark for an adaptive deep brain stimulation (DBS ... he said. Medtronic’s diabetes business has turned around and is growing in the double ...

Medtronic Vietnam and University Medical Center Ho Chi ... This includes the first successful treatment of an epilepsy patient with deep brain stimulation, and training courses, both locally and ...